The joint Egyptian-Turkish military drill "Golden Eagle" kicked off on Wednesday with the participation of the Egyptian ...

HIS RECOMMENDATIONS MORE THAN THREE YEARS AGO. STACEY, NATALIA, THANK YOU. AND A WOMAN IS GRIEVING. EARLIER THIS WEEK, A SHOOTING LEFT HER HUSBAND INJURED AND HER SON DEAD. THE TRAGIC INCIDENT ...

A shooting in Adel Monday night left one dead and another injured. Adel police responded to a report of shots fired just before 8 p.m. on Monday, June 8, in the 1600 block of Pleasant Street, ...

CALL AHEAD TO CONFIRM WHETHER A LOCATION IS OPEN OR NOT. WELL, BREAKING NEWS, ONE PERSON IS DEAD AND ANOTHER IS INJURED AFTER A SHOOTING IN ADEL LAST NIGHT. ADEL POLICE SAY IT HAPPENED ON THE 1600 ...

AI Quick Read The second son of the late Iranian supreme leader, Mojtaba Khamenei, has been named as his successor, Iranian state TV reported on Sunday. US‑Israeli strikes killed Ayatollah Ali ...

Mojtaba Khamenei, son of Iran’s late supreme leader, has been named his successor, Iranian state TV reported. The announcement comes nine days after US‑Israeli strikes killed Ayatollah Ali Khamenei.

The US and Israel's assassination of Ayatollah Ali Khamenei, the Supreme Leader of Iran, has thrown the country's complex power dynamics into uncertainty. Amid the chaos, one name has surfaced as a ...

Mojtaba Hosseini Khamenei, son of Ayatollah Ali Khamenei, has reportedly been chosen as Iran's new supreme leader. Daily Mail reported on the development, citing Iranian TV network. It comes after ...

ADEL, Ga. (WALB) – A fire broke out at Michelle’s Formal Wear early Tuesday morning, sending heavy smoke into the area of 4th Street and Burwell Avenue. According to a post shared on the store’s ...

Chandigarh: Tightening the noose further around builders and colonisers who duped thousands of homebuyers in Gurugram, Palwal and Faridabad, the Directorate of Enforcement (ED) on Saturday attached ...

Korean biopharmaceutical company Adel announced Monday that it has secured a license-out agreement worth up to $1.04 billion with multinational health care firm Sanofi for the development and ...

ADEL-Y01, a monoclonal antibody targeting tau protein, is in Phase I trials for Alzheimer's disease, developed by ADEL and licensed to Sanofi. The ADEL-Sanofi agreement is valued at over $1.04 billion ...